Sign In
Buy BMO
$165.21
+2.88 (+1.77%)
At Close: Jun 04, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
12:00pm, Saturday, 19'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to conta
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
09:43pm, Thursday, 17'th Oct 2024
NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE: BMO). Such investors are advised to contact D
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
08:30pm, Tuesday, 15'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to conta
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
12:00pm, Sunday, 13'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to conta
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
05:00pm, Friday, 11'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to conta
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
05:41pm, Wednesday, 09'th Oct 2024
NEW YORK , Oct. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE: BMO). Such investors are advised to contact Da
BMO Capital Markets Raises Price Target on Vistra Corp
12:45pm, Tuesday, 08'th Oct 2024
Vistra Corp. (VST, Financial), a prominent player in the energy sector, is experiencing the best time ever, surging more than 240% this year. While several analysts have taken a bullish stance on the
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
05:15pm, Monday, 07'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to contac
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
12:00pm, Saturday, 05'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to contac
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
10:30am, Thursday, 03'rd Oct 2024
NEW YORK , Oct. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE: BMO). Such investors are advised to contact Da
Is the Options Market Predicting a Spike in Bank of Montreal (BMO) Stock?
09:40am, Thursday, 03'rd Oct 2024
Investors need to pay close attention to Bank of Montreal (BMO) stock based on the movements in the options market lately.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
04:20pm, Tuesday, 01'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to contac
Foghorn Therapeutics to Participate in the BMO Oncology Summit
07:00am, Tuesday, 01'st Oct 2024
CAMBRIDGE, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases b
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
10:00am, Sunday, 29'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE: BMO). Such investors are advised to co
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bank of Montreal - BMO
05:15pm, Friday, 27'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Bank of Montreal ("BoM" or the "Company") (NYSE:BMO). Such investors are advised to con
